On the Agenus HerpV vaccine trials

Two readers recently asked me about the Agenus HerpV trials.  Given that this is a topic of broad concern to genital herpes sufferers, I have converted the original query and my response to a blog post as follows. – Bill H. ————————————— November 8, 2013 Dr. Halford, Agenus released their initial phase 2 results: http://www.antigenics.com/docs/press-releases/2013/herpv-vaccine-for-genital-herpes-meets-primary-endpoint.php […]

Halford HSV-2 Vaccine Research Highlights

Since setting up this blog in June 2013, I have received several inquiries about how my research fits into the broader topic of the field of HSV-2 vaccine research.  To address such questions in advance, I provide a brief summary below. For anyone interested in all the details, a quick visit to PubMed (http://www.ncbi.nlm.nih.gov/pubmed) followed […]